Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

IDEXX Laboratories Inc (NASDAQ:IDXX)

67.85
Delayed Data
As of Feb 12
 +0.58 / +0.86%
Today’s Change
61.37
Today|||52-Week Range
82.24
-6.95%
Year-to-Date

Today’s Trading

Previous close67.27
Today’s open68.09
Day’s range66.82 - 68.86
Volume1,039,847
Average volume (3 months)750,806
Market cap$6.2B
Dividend yield--
Data as of 4:00pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)+14.53%
Earnings growth (this year)+1.33%
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)+7.81%
P/E ratio37.1
Price/Sales4.26
Price/Book--

Competitors

 Today’s
change
Today’s
% change
UTHRUnited Therapeutics ...+4.95+4.07%
TAROTaro Pharmaceutical ...+1.87+1.42%
MNKMallinckrodt Plc+1.83+3.02%
JAZZJazz Pharmaceuticals...+1.06+0.94%
Data as of 4:02pm ET, 02/12/2016

Financials

Next reporting dateApril 26, 2016
EPS forecast (this quarter)$0.47
Annual revenue (last year)$1.6B
Annual profit (last year)$192.1M
Net profit margin11.99%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Jonathan W. Ayers
Chief Financial Officer, Treasurer &
Executive VP
Brian P. McKeon
Corporate headquarters
Westbrook, Maine

Forecasts

Partner Offers